close
close

Bio-Gene and Envu collaborate to evaluate Flavocide™ for use in mosquito management in the public and private sectors


Bio-Gene and Envu collaborate to evaluate Flavocide™ for use in mosquito management in the public and private sectors

Vector-borne diseases account for more than 17% of all infectious diseases and cause over 700,000 deaths annually. They can be caused by parasites, bacteria or viruses. Malaria is a parasitic infection transmitted by Anopheles mosquitoes. It causes an estimated 219 million cases worldwide and results in more than 400,000 deaths each year. Most deaths occur in children under 5 years of age. (Photo: Business Wire)

Highlights

  • Joint collaboration to evaluate Flavocide for mosquito control in a range of professional applications

  • Flavocide complements Envu’s range of cutting-edge, effective chemicals for the global professional non-plant market

  • Flavocide is proven to be effective in controlling mosquitoes

MELBOURNE, Australia & CARY, NC, August 14, 2024–(BUSINESS WIRE)–Bio-Gene Technology Limited (ASX:BGT or “Bio-Gene”), an Australian company developing the next generation of novel bio-insecticides, and Envu are evaluating Flavocide™ for use in professional pest control and healthcare products for mosquito control.

Envu, a global company focused on environmental science, develops innovative solutions to control insects, weeds and turf diseases that threaten public health and the environment. With its ESG pillars, Envu is committed to nature-friendly innovations. As a nature-identical compound, Flavocide complements the company’s professional product portfolio for pest and mosquito control.

This collaboration combines Bio-Gene’s research and development pipeline with Envu’s formulation expertise to maximize efficacy and application efficiency. Bio-Gene and Envu have successfully tested several formulations of Flavocide for mosquito control and will continue to test Flavocide for a range of professional-use products to control these health-damaging pests.

Tim Grogan, Managing Director and CEO of Bio-Gene said: “Our collaboration with Envu expands the potential of Flavocide for use in key professional pest control and public health target markets worldwide to control mosquitoes. Envu is a global leader in the commercial development and commercialization of new and sustainable mosquito control products. This important program supports our strategy of working with a number of strong partners to fully leverage the capabilities of our technologies.”

Bernard Jacqmin, Senior Vice President – ​​Head of Global Innovation at Envu said: “We are pleased to be working with Bio-Gene to develop and evaluate Flavocide for use in mosquito control. Flavocide is a natural product and has shown a favorable profile in mosquito control based on our testing to date. Our joint efforts are already showing promising results in the testing phase and we are excited about the potential benefits for consumers and professionals in this field.”

Flavocide is a nature-identical product based on flavesone, a naturally occurring plant compound found in some species of eucalyptus. Bio-Gene has developed a proprietary process to synthesize the molecule and produce it in commercial quantities.

Flavocide has a new mode of action – the way an insecticide controls or kills insects – and is able to overcome insect resistance to current insecticide products. Mosquito strains can become particularly resistant to existing products, making it difficult to control the spread of major diseases such as malaria, dengue fever and Zika virus. Insecticides with new modes of action are rare and essential to ensure future global food security and public health.

Bio-Gene is developing Flavocide to address the major global problem of insecticide resistance in public health, crop protection, grain storage and consumer applications.

Currently, Bio-Gene and Envu are evaluating opportunities for Envu to use Flavocide in commercial products. Future development or licensing agreements will be announced jointly by Bio-Gene and Envu.

Released for publication by Bio-Gene and Envu.

About Bio-Gene Technology Limited

Bio-Gene is an Australian company developing novel bioinsecticides to address the global problems of insecticide resistance and toxicity. Its unique products are based on a naturally occurring class of compounds proven to overcome pest resistance with minimal impact on human health and the environment.

Bio-Gene’s products have applications in a wide range of areas including crop protection, grain storage, healthcare and consumer applications, offering new, nature-derived options to meet market demand for effective and safe pest control solutions.

Flavocide™ is a trademark of Bio-Gene Technology Limited.

About Envu

Founded in 2022, Envu is a company built on years of experience in environmental science with a sole purpose of promoting a healthy environment for everyone, everywhere. Envu offers specialized services in the following areas: professional pest control, forestry, ornamentals, golf, industrial vegetation management, turf and landscaping, mosquito control, and pasture. Envu partners with customers to develop innovative solutions that meet their needs today and in the future. The Envu portfolio consists of over 180 trusted and well-known brands. The company employs 900 people, operates in 100 countries, and has four global innovation centers. For more information, visit www.envu.com.

View original version on businesswire.com: https://www.businesswire.com/news/home/20240813495113/en/

Contacts

For further information please contact:

Bio-Gen:
Adrian Mulcahy, Investor Relations
[email protected]
0438 630 422

Tristan Everett, Media Relations
[email protected]
0403 789 096

Vicinity:
Jennifer Poore, Head of Corporate Communications
[email protected]
+011 1 919 475 5814

Leave a Reply

Your email address will not be published. Required fields are marked *